Aligos Therapeutics Stock Price

0.19 (1.21%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aligos Therapeutics Inc ALGS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.19 1.21% 15.84 18:00:19
Open Price Low Price High Price Close Price Prev Close
15.81 15.32 15.92 15.84 15.65
Bid Price Ask Price Spread News
15.31 18.00 2.69 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,430 77,421 $ 15.75 $ 1,219,682 - 12.82 - 37.5099
Last Trade Time Type Quantity Stock Price Currency
16:01:00 formt 158 $ 15.84 USD


Draw Mode:

Aligos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 674.92M 42.61M 19.12M $ - $ - -11.62 -1.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 60.00k 7.40%

more financials information »

Aligos Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALGS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.3416.5614.8015.80354,534-0.50-3.06%
1 Month15.9717.5514.5015.83319,341-0.13-0.81%
3 Months18.4518.4913.8615.96313,328-2.61-14.15%
6 Months22.3334.3113.8618.85199,123-6.49-29.06%
1 Year14.7437.509912.8220.23177,7391.107.46%
3 Years14.7437.509912.8220.23177,7391.107.46%
5 Years14.7437.509912.8220.23177,7391.107.46%

Aligos Therapeutics Description

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Your Recent History
Aligos The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.